In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

BACKGROUND: Rheumatoid arthritis (RA) is characterized by the presence of autoantibodies like rheumatoid factor (RF), anti-cyclic citrullinated peptide-2 (anti-CCP2), and anti-carbamylated protein (anti-CarP) antibodies. It is currently unclear whether changes in autoantibody levels are associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: de Moel, Emma C., Derksen, Veerle F. A. M., Trouw, Leendert A., Bang, Holger, Collée, Gerard, Lard, Leroy R., Ramiro, Sofia, Huizinga, Tom W. J., Allaart, Cornelia F., Toes, René E. M., van der Woude, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339446/
https://www.ncbi.nlm.nih.gov/pubmed/30658699
http://dx.doi.org/10.1186/s13075-019-1815-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339446/
https://www.ncbi.nlm.nih.gov/pubmed/30658699
http://dx.doi.org/10.1186/s13075-019-1815-0

Ejemplares similares